Abstract
The objective was to evaluate the relative efficacy of cryoablation (CRYO) versus external beam radiation (EBRT) for clinically locally advanced prostate cancer in a randomized clinical trial. Patients with histologically proven, clinically staged as T2C, T3A or T3B disease were randomized with 6 months of perioperative hormone therapy to one of the two procedures. Owing largely to a shift in practice to longer term adjuvant hormonal therapy and higher doses of radiation for T3 disease, only 64 out of the planned 150 patients were accrued. Twenty-one of 33 (64%) in the CRYO group and 14 of 31 (45%) in the EBRT-treated group who had met the ASTRO definition of failure were also classified as treatment failure. The mean biochemical disease-free survival (bDFS) was 41 months for the EBRT group compared to 28 months for the CRYO group. The 4-year bDFS for EBRT and CRYO groups were 47 and 13%, respectively. Disease-specific survival (DSS) and overall survival (OS) for both groups were very similar. Serious complications were uncommon in either group. EBRT patients exhibited gastrointestinal (GI) adverse effects more frequently. Taking into account the relative deficiency in numbers and the original trial design, this prospective randomized trial indicated that the results of CRYO were less favorable compared to those of EBRT, and was suboptimal primary therapy in locally advanced prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Soaves WA, Gander MJ, Schulman S . Apparatus and techniques for cryosurgery of the prostate. J Urol 1966; 96: 508–511.
Flocks RH, Nelson C, Boatman DL . Perineal cryosurgery for prostate cancer. J Urol 1972; 108: 933–935.
Onik G, Cohen J, Reyes GD, Rubinsky B, Chang Z, Baust J . Tran rectal ultrasound-guided percutaneous radical cryosurgery ablation of the prostate. Cancer 1993; 72: 1291–1299.
Shinohara K, Connolly JA, Presti Jr JC, Carroll PR . Cryosurgical treatment of localized prostate cancer (stages T1–T4): preliminary results. J Urol 1996; 156: 115–121.
Miller RJ, Cohen JK, Merlotti LA . Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology 1994; 44: 170–174.
Shipley WU, Prout GR, Coachman MM, McManus PL, Healey EA, Althausen AF et al. Radiation therapy for localized prostate carcinoma: experience of the Massachusetts General Hospital 1973–1981. NCI Monographs 1988; 8: 67–73.
Hanks GE . Treatment of earlier stage prostate cancer. In: Devita VT, Hillman S, Rosenberg SA (eds). Radiotherapy. Important Advanced in Oncology. JB Lippincott Company: Philadelphia, 1994, pp 225–239.
Pilepich MV, Buzydlowski JW, John MJ, Rubin P, McGowan DG, Marcial VA . A. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83–07. Int J Rad Onc Biol Phys 1995; 32: 175–180.
Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomized trial. Lancet 2002; 360: 103–106.
Zelefsky MJ, Leibel SA, Burman CM, Kutcher GJ, Harrison A, Happersett L et al. Neoadjuvant hormone therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with 3-dimensional conformal radiation therapy. Int J Rad Onc Biol Phys 1994; 29: 755–761.
Chin JL, Downey DB, Onik G, Fenster A . 3-dimensional prostate ultrasound and its application to cryosurgery. Tech Urol 1996; 2: 187–193.
Chin JL, Downey DB, Mulligan M, Fenster A . A: 3-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in non-surgical candidates: a feasibility study and report of early results. J Urol 1998; 159: 910–914.
Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB . Results of cryoablation of the prostate after radiation: identifying predictors for treatment failure and complications. J Urol 2001; 165: 1937–1941.
ASTRO Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Rad Oncol Biol Phys 1997; 37: 1035.
Kuban D, Thamses H, Levy L, Horwitz E, Kupelian P, Martinez A et al. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? Int J Rad Onc Biol Phys 2005; 61: 409–414.
Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V et al., Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 2003; 21: 3972–3978.
Prepelica KL, Okeke Z, Murphy A, Katz AE . Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005; 103: 1625–1630.
Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M . Targeted cryoablation of the prostate: 7-year outcome in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl 1): 3–11.
Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW et al. Prospective trial of cryosurgical ablation of the prostate: five year results. Urology 2002; 60: 645–649.
Ellis DS . Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 2002; 60 (2 Suppl 1): 34–39.
Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multi-center experience. J Urol 2003; 170: 1126–1130.
Acknowledgements
This work is supported by a research Grant from AstraZeneca, Canada.
Author information
Authors and Affiliations
Corresponding author
Additional information
The subject matter of this manuscript has been presented, in part or in whole, at (1) Canadian Urological Association Annual Meeting, June 2005; (2) Northeastern Section of American Urological Association Annual Meeting, November 2005; (3) American Urological Association Meeting, May 2006; (4) Canadian Association of Radiation Oncology Annual Meeting 2005.
Rights and permissions
About this article
Cite this article
Chin, J., Ng, CK., Touma, N. et al. Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis 11, 40–45 (2008). https://doi.org/10.1038/sj.pcan.4500988
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500988
Keywords
This article is cited by
-
Comparative results of focal-cryoablation and stereotactic body radiotherapy in the treatment of unilateral, low-to-intermediate-risk prostate cancer
International Urology and Nephrology (2022)
-
Möglichkeiten der Kryotherapie beim Prostatakarzinom
Der Urologe (2018)
-
Cryosurgery would be An Effective Option for Clinically Localized Prostate Cancer: A Meta-analysis and Systematic Review
Scientific Reports (2016)
-
Can we deliver randomized trials of focal therapy in prostate cancer?
Nature Reviews Clinical Oncology (2014)
-
Expressions of MVD, VEGF, Ki67 in residual prostate cancer after cryoablation
Clinical Oncology and Cancer Research (2011)